CarePair for Dementia Caregivers
(CarePair Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new app called CarePair, designed to assist family caregivers of people with dementia. The app aims to reduce stress, depression, and feelings of being overwhelmed by providing personalized resources and support. Caregivers will use the app for six weeks, and researchers will assess its impact on their well-being compared to a group using a non-personalized digital folder. It suits primary caregivers who have provided at least 10 hours of care per week for six months and live in specific areas like New York City, Seattle, or Los Angeles. As an unphased trial, this study offers caregivers a unique opportunity to access innovative support tools and contribute to valuable research.
Do I need to stop my current medications to participate in the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on using a mobile app for caregivers, so it's unlikely that medication changes are required.
What prior data suggests that the CarePair mobile application is safe for caregivers?
Research shows that specific safety information for the CarePair app is not available. Designed to assist caregivers of people with dementia, the app provides personalized advice and resources. As a mobile app, not a medication or medical device, typical safety concerns like side effects do not apply.
Mobile health apps like CarePair are generally considered low risk, focusing on information and resources rather than medical treatment. Users do not face the same safety issues as with other medical treatments. In the realm of mobile apps for dementia caregivers, the main goal is to offer support and reduce stress.
While researchers continue to study the CarePair app, mobile apps in general are seen as a safe way to help caregivers manage their responsibilities better.12345Why are researchers excited about this trial?
CarePair is unique because it offers a personalized approach to supporting dementia caregivers. Unlike traditional support options that often provide generic information, CarePair uses a digital platform to tailor educational content and resources specifically to each caregiver's needs and preferences. This individualized attention can potentially make caregiving more manageable and effective. Researchers are excited about CarePair because it could revolutionize how caregivers access and utilize information, making their caregiving journey more efficient and less stressful.
What evidence suggests that the CarePair app is effective for dementia caregivers?
Research has shown that mobile apps like CarePair, which participants in this trial may receive, can assist family members caring for people with dementia by providing personalized resources and reducing stress. Studies have found that online and mobile app tools for dementia caregivers can improve mental health by lowering feelings of burden and depression. Reviews suggest that many current apps lack customized information, which is crucial for supporting caregivers. CarePair addresses this by offering personalized advice based on the caregiver's needs. Early results indicate that these personalized tools can boost caregivers' confidence, helping them manage their caregiving duties more effectively.12367
Who Is on the Research Team?
Francesca Falzarano, PhD
Principal Investigator
University of Southern California
Are You a Good Fit for This Trial?
This trial is for family caregivers of individuals with dementia. Participants should be willing to use the CarePair web application and engage in study activities over three months. Specific eligibility criteria are not provided, but typically participants must meet certain conditions related to their situation as caregivers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Training and Baseline Assessment
Caregivers are introduced to and trained in the use of the CarePair application through video tutorials, written instructions, and virtual training sessions. Baseline interviews are conducted.
Intervention
Caregivers use the CarePair application for six weeks, completing bi-weekly questionnaires assessing service use and satisfaction.
Follow-up
Participants complete a follow-up survey and an optional interview to provide feedback on their experience with the CarePair application.
What Are the Treatments Tested in This Trial?
Interventions
- CarePair
Trial Overview
The trial is testing CarePair, a web-based platform designed to help dementia family caregivers by assessing needs and referring services. It aims to reduce caregiver stress and improve well-being through feasibility, acceptability, depression alleviation, burden reduction, and self-efficacy enhancement.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants randomized to the intervention arm will receive access to the CarePair app, a needs-based digital platform that delivers tailored recommendations for Alzheimer's disease and related dementias (ADRD) resources designed for family caregivers. These include services and educational articles personalized based on the caregiver's self-reported needs and preferences, with content organized by relevance to each user. Participants will be asked to log into the CarePair app twice per week and engage with one article per login, for a total of 12 logins and articles over the 6-week study period.
Participants randomized to the control arm will receive access to an attention-matched comparator: a digital folder containing the same caregiving articles available in the CarePair app. However, the materials will not be personalized or organized. Participants will be asked to log into the digital folder twice per week and read one article at each login, for a total of 12 logins and articles over the 6-week study period, mirroring the engagement frequency of the intervention group.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Southern California
Lead Sponsor
National Institute on Aging (NIA)
Collaborator
Published Research Related to This Trial
Citations
1.
clinicaltrials.gov
clinicaltrials.gov/study/NCT06418971?locStr=United+States&country=United+States&aggFilters=healthy%3Ay%2Cstatus%3Anot+rec+enr+unk&firstPost=2024-01-01_Testing & Refinement of CarePair: An Assessment and ...
The purpose of this study is to develop and test CarePair, a mobile application-based needs assessment and service referral platform for family caregivers ...
CarePair for Dementia Caregivers
The purpose of this study is to develop and test CarePair, a mobile application-based needs assessment and service referral platform for family caregivers ...
Researched Apps Used in Dementia Care for People Living ...
This review seeks to understand the landscape of existing mobile apps in dementia care for people living with dementia and their caregivers.
Effectiveness of Internet-Based or Mobile App Interventions ...
This study evaluated the effectiveness of internet-based or mobile app interventions for family caregivers of older adults with dementia.
mHealth Apps for Dementia Caregivers - JMIR Aging
Existing dementia care apps do not provide sufficient high-quality, tailored information for informal caregivers.
Are mobile apps meeting the needs of caregivers of people ...
Innovations in mobile health can improve the delivery of and access to interventions for caregivers of people living with dementia.
Mobile Apps to Support Family Caregivers of ... - JMIR Aging
The aims of our study were to identify existing mobile apps designed to support family caregivers of people with Alzheimer disease and related dementias in ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.